Where To Invest October 2016 Report

Where to invest newsletter


Read the October 24, 2016 — Where To Invest in October 2016 Market Investing Strategies Newsletter in .pdf format Here


October 24, 2016

Market Strategies Newsletter – Sample Issue

Where To Invest October 2016

Where to Invest for quick progfits in July 2016 News


Where To Invest Balanced Investing Strategies

To Make Money In Up Or Down Markets

A Publication of Princeton Research, Inc. (www.PrincetonResearch.com)

Contributing Staff: Michael King, Charles Moskowitz


Where To Invest In 2016 Newsletter Covering:

Where To Invest October 2016

Investing Trade Alerts

Text Message Investing Alerts

Options Trading Alerts Service

Undervalued Small Cap Stocks

Stocks To Buy With Stops October 2016



Proven Trading Profits

Results From Recent Text Message Investing Trade Alerts:


123% Profits on SPY Oct 19 Puts in 2 Days

300% Profits on SPY Oct 12 Puts in 2 Days

15% Profits on SPY Oct 19 Puts in 2 Days

50% Loss on LMT Calls in 1 Day

45% Profits on SFM Calls in 6 Days

50% Profits on TBT Calls in 8 Days

86% Profits on AA Calls in 6 Days

66% Profits on SPY Puts in 2 Days

47% Profits on SLV Calls in 3 Days


Join Today to Start Getting Profits Like These.


We Do The Analysis Work
We Send You The Trades
You Make The Trades
You Take Your Gains



NOTE: This is a Sample Issue Only!



Visit: PrincetonResearch.com/join.htm



For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm
Investing strategies newsleter


Go To http://www.princetonresearch.com/join.htm

To get the lowest full membership rates available now.


Where To Invest October 2016

Options Investing Trade Alerts

Charles Moskowitz Discussion


Week 42 produced a loss of $264 bringing YTD performance back to $7,571 with only 1 open small (half) position in SPY 10/28 213 puts @ $1.03.  Funds in use total $412.


The market did nothing this week with the S&P500 having an inside week with a total range of only 24 points and a net change of only .38%.   The internals were slightly positive but not enough to give us any hint of direction.  Even though the US$ was higher, so was Oil and Gold. The Russell, devoid of large-cap internationals and supposedly immune to the dollar saw a decline of almost 2%. The A.A.I.I. numbers are also confounding with the bears now at 37.8 or 20% over average, bulls are 23.7 or 40% under average and neutral are 38.4 and 20% above average.  This is not what market corrections are made of, and yet the chart below couldn’t look more dangerous to me: the A.A.I.I. survey with Bull now 30% below avg, Bears 10% above and Neutral still the highest reading @ 40.8% still over 33% above average.  So while I’m trading from the short side primarily, we are not nearly done with the long term upside. However, after looking a lot of charts this weekend the group that looks the most ready to rally is the VIX, VXX and the leveraged reverse indexes…not a great way to start the week.


We have the 3 distinct tops in August and the massive $54 break 9/9.  We rally but can’t get back above the gap from that gap @ 2180 and consolidate until 10/10 when we break again.  This formation from 9/9 to 10/10 is a “bear flag” and the action since then has not been able to close above 2150.  All during this time the momentum is trailing off and OBV is actually making new lows. However, if it goes on much longer it will start to look like just another consolidation and will favor the seasonal upside bent to the market in the November/December period.


Last, but not least, I want to comment on our stock position in SAM.  We own it with a $154 average and while I don’t generally like to hold high-priced stocks into earnings we had a little cushion.  Earnings were Thursday after the close and the stock was $156 and traded down to $148 and back to 153, not too bad.  Then came the conference call and when it opened Friday it traded down to 145, but started up and closed @ $163+6.75.  Just goes to show, sometimes you’re the hammer and sometimes you’re the nail…CAM



Options Investing Trade Alerts Summary


10/19 Bought 4 SPY October 213 Puts  1.03  412
10/19 Sold 4 AMBA October 65 Calls  0.95       380        60 Loss
10/18 Sold 4 SPY October 212 Puts  0.42       168      204 Loss
10/14 Bought 4 SPY October 212 Puts  0.93  372
10/13 Bought 4 AMBA October 65 Calls  1.10  440


3rd Week expiration when the month is listed without a date


Previous closed out trades not listed here may be seen in previous market letters in the

VIP Subscribers Members Area.


Remember, these trades are based on your participation in the

Subscriber Members Only




NOTE: In texting we have a limited amount of words. In the interest of brevity:


The Quantity and Strike Price for each trade is specific. 1=January, 2=February


Trading is hypothetical. We may trade weekly options and they are noted: SPY 1/25 147 for

SPY Jan 25th 147 Calls or Puts.



For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm





Go To http://www.princetonresearch.com/join.htm

To get the lowest full membership rates available now.


Where To Invest October 2016

Undervalued Small Cap Stocks


Lower Priced stocks that look to be a buy: 


Repro-Med Systems,Inc  ( OTCQX:  REPR 0.41 )* 


For the quarter ended August 31st, net revenues were $3,147,930 compared with $3,166,177 in the comparable quarter last year. REPR had strong organic growth both domestically and internationally in the quarter as well as new customer wins, which are expected to continue going forward. Results were masked by the non-recurring contribution from a large clinical trial last year. Net revenues increased in Q2 compared with Q1 of the current fiscal year by 5%.


For the six months ended August 31st, net revenues were $6,138,096, an increase of 5.9% compared with $5,796,722 for the same period last year, driven by increased sales of infusion products to existing customers as well as the addition of new customers.


For the three months ended August 31st, gross profit was $1,954,592 compared with $2,006,729 for the same period last year.  RMS continues benefiting from lean manufacturing initiatives to streamline operations, which have resulted in increased capacity and decreased direct assembly labor costs, as well as the moratorium on the medical device tax.  For the six months ended August 31st, the gross profit margin increased 2.6% to 63.4%, up from 60.8% for the same period last year.  Gross profit for the six months ended August 31st was $3,891,404 compared with $3,524,589 for the comparable period.


RMS continues to incur professional fees related to regulatory and litigation and has made significant investment over the last twelve months in its sales, regulatory and operations management to help launch RMS to the next level of growth. As a result, the Company reported for the quarter ended August 31st, a net loss of $82,612, compared to net income of $335,214 in the same period last year.  For the six months ended August 31st, net loss was $315,928 compared with net income of $270,574.



Enzo Biochem ( ENZ: $ 5.93 )*


The stock moved from approximately $5 a share to approximately $7.00 from May 1 to July.


In the last few days Enzo stock has been under heavy pressure. There is nothing fundamental to cause the slide in price. So the business model remains in place and hopefully will add new products over the remainder of the year. They completed the 2016 fiscal year at the end of July and probably had a cash position of some $65 million and no debt to speak of. When the stock cleared the $7 level, the Relative Strength Index was over 70, which is overbought. That $7 number was a 4 year high The last two days has brought the Index close to 30 which is oversold and we should see a bounce in the stock price this week.(just a guess) We have to remember the Russell Indexes that bought close to 3 million shares in late June also shorted close to a million shares as a hedge. That short position declined by some 300,000 shares from July 1 to July 15.


Over the rest of the year we could see more AmpiProbe panels being approved; NIH comments on the Optiquel trial for Uveitis; positive outcomes in the litigations.


The stock is oversold and the upside opportunity becomes bigger. The fundamentals haven’t changed and in fact have become stronger with the latest AmpiProbe approval. Enzo has cash of $50 million and no debt. There are 7 more cases to get settled in Delaware which can provide significant additions to the cash position. AmpiProbe will have more submissions to the New York regulatory agency this year. AmpiProbe is cheaper, better and faster than existing technology and that is a $3 billion market.


This is an awesome potential for a 47 million share company and who knows what will happen if the NIH has positive statements on their Optiquel test for Uveitis. The stock is 50% owned by Institutions and funds, 15% by insiders and I guess 10% by hedge funds. That leaves some 11 million shares in the float. If the Russell causes 2-3 million shares to be bought the float then become 8-9 million shares. Good news can really move the price.



Pressure BioSciences OTCQB: PBIO ( 0.34 )*


has identified significant “needs” and the means to fill them in the world of today and the foreseeable future:


NEEDS IN MEDICINE: In the world of medicine our dramatically improved ability for early detection or to confirm and refine diagnosis ranging from over a hundred types of cancer to tuberculosis and a hundred other maladies and conditions is “bottlenecked” by 30 year old methods of preparing test samples.  Collectively such diagnostic samples exceed a hundred million annually.


NEEDS IN RESEARCH: Globally there are over a half a million medical and pharmaceutical research scientists working in over eighty thousand laboratories who are hampered by the time consuming and outdated methods of preparing test samples.


NEEDS IN FORENSICS: Globally, in millions of cases, swift and sure exoneration of the innocent and / or justice for the guilty is often delayed or even denied because of the ponderous means of preparing and conducting DNA and other forensic testing.


PBIO is focused on solving the challenges of biological sample preparation, a crucial laboratory step performed globally by the biological life sciences research scientists. Sample preparation refers to a wide range of activities that precede most forms of scientific analysis. It is often complex, time-consuming and, in our opinion, one of the most error-prone steps of scientific research. Sample preparation is a ubiquitous laboratory undertaking – the requirements of which drive a large and growing worldwide market.


PBIO has developed and patented a novel, enabling technology platform that can control the sample preparation process while improving both efficacy and quality.  It is based on harnessing the unique properties of high hydrostatic pressure. This process, called pressure cycling technology, or PCT, uses alternating cycles of hydrostatic pressure between ambient (normal atmosphere) and ultra-high levels i.e., 35,000 pounds per square inch (“psi”) or greater to safely, conveniently and reproducibly control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant and microbial sources.


The PBIO pressure cycling technology uses proprietary and internally developed instrumentation that is capable of cycling pressure between ambient and ultra-high levels at controlled temperatures and specific time intervals, to rapidly and repeatedly control the interactions of bio-molecules, such as deoxyribonucleic acid (“DNA”), ribonucleic acid (“RNA”), proteins, lipids and small molecules. Their laboratory instrument, the Barocycler®, and their internally developed consumables product line, which include Pressure Used to Lyse Samples for Extraction (“PULSE”) tubes, and other processing tubes, and application specific kits such as consumable products and reagents, together make up their PCT Sample Preparation System (“PCT SPS”).


The PBIO pressure cycling technology takes a unique approach that has the potential for broad use in a number of established and emerging life sciences areas, which include:


  • Biological sample preparation in potentially thousands of research laboratories worldwide working in human, animal, plant, and microbial diseases and disorders – including but not limited to sample extraction, homogenization, and digestion in genomic, proteomic, lipidomic, metabolomic and small molecule study areas;


  • Pathogen inactivation (useful in vaccine development, infectious disease research, and more);


  • Protein purification, and in the control of chemical reactions, particularly enzymatic (useful in drug design and development);


  • And immunodiagnostics (useful in the development and detection of biomarkers).




PBIO has secured their technology through fourteen issued United States patents and ten issued foreign patents covering multiple applications of pressure cycling technology in the life sciences field.  They also have additional patents pending.  Research indicates that Pressure BioSciences Inc is the ONLY Company globally to have patents in this new science sector.




Night Food, Inc. ( NGTF.0.10 )* 


is a wholly-owned subsidiary of Night food Holdings incorporated in Nevada in 2013 to manufacture and distribute healthy-choice bedtime snacks. The Company has an exclusive agreement with RFI, natural ingredient manufacturer and proprietor of Chocamine, a patented chocolate ingredient


Americans keep gaining more weight. People have the tendency to grab for goodies at the end of the evening as they relax to enjoy some T.V. Eating and snacking too late at night is a contributing factor to gaining weight. Seventy percent of adults, ages 18-54, eat right before bed. Chocamine delivers the health benefits of chocolate to the body (amino acids, minerals and polyphenols) without the added sugars, caffeine or fat.


People give in to the intense hunger cravings that leads to the consumption of sugary, salty or calorie dense foods to satisfy their appetite. Most of the snacks that people typically eat create a disturbance in sleep, causing a person to wake up feeling unrested. Night Food offers nutrient filled alternatives to high-calorie junk foods. There are flavor filled snack bars-either Cookies and Dreams or Midnight Chocolate Crunch that will help curb hunger, satisfy cravings, improve rest and give the body essential vitamins and minerals. Consumers spend over $50 billion/ year on night-time snacks, nearly 1 billion a week.  More people desire healthy alternatives to late night consumption of the traditional fattening ice cream, chips and cookies.


Sugar and caffeine in most snacks causes disruptive sleep. Each bar has only 142 calories and 5 grams of fiber for slow absorption of energy and gives a feeling of fullness and satisfaction. There is also 132 mg of calcium and zinc for replenishing the body and feeling well rested in the morning.



iSIGN Media Solutions ( ISDSF: $ 0.085 )


Announces Signed Contract Between We Build Apps and a Major Shopping Complex Located in Ohio. The contract covers installation of 500 Smart Antennas into a first Shopping Complex; Minimum Revenue to iSIGN is $2.7 million Canadian.

Recent news has pushed it above its 30 day moving average and it had exceeded $0.15 Canadian on a high volume breakout. The stock has been disappointing failing to move above its next resistance at $0.20 and move towards its 2 yr high of $0.28.


The Crocker people and their 22 developments could bring iSign significant revenues. Homeland Security and a major insurance company deemed the smart antenna as a safety device as well as a security device making the potential for new markets is limitless. One deal brings in 3 million times that by 20 deals because the insurance company theoretically gives a 20-25% premium discount to companies that use the smart antenna.

According to the iSign Media reseller, JEA Technologies, eHealth Consortium Group’s intention is to start installations in hospitals located in the State of Victoria.



Leo Motors ( LEOM: $ 0.19 )*


has patents for the electric battery industry which we will be writing about in upcoming weekly reports. They have developed a lithium battery that can operate vehicles  in sub-zero climates. Their subsidiary LGM has developed battery technology supported by the Korean government to make it possible to use electric battery technology for fishing boats. They have a cartridge system which is a light-weight replacement method of swapping electric batteries.


Fishing has been harmed by the noise and oil leaks from internal combustion engines. LGM has solved that problem and besides eliminating the toxic problem, operating costs are reduced by 25%.


In addition they have a special patent for averting electric hazards and shocks. Leo developed the Internet of Things for e-boats which is networked and connected with an Android Operating System. Leo’s power supply system is CAN ( Controller Area Network ) based, which enables mobile diagnosing  between mobile devices and boats using the Leo technology.


Leo is developing a battery swap system for Kalmado in Puerto Princesa, Philippines which is a world famous tourist attraction. They will be converting 100 boats as the environment is expected to become 100% free of the toxicity from internal combustion engines. Also, Leo has developed a battery swap system for Go-Karts to be used in malls in China, Korea and Myanmar.


Leo Motors has a new carbon nanotube battery power pack that functions and supplies full power in extreme low temperatures such as below 49 degrees without the need for grid electricity.

NOTE: This is a Sample Issue Only!



Visit: PrincetonResearch.com/join.htm



For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm





Go To http://www.princetonresearch.com/join.htm

To get the lowest full membership rates available now.


Where To Invest October 2016

Where To Invest October 2016

Stocks To Buy October 2016

Fundamental Analysis Stocks To Buy with Stops


Using fundamentals the following are stocks to buy and they have done well.


The table is hypothetical. We have taken numerous profits as indicated on the table below.


Balance is critical.


The Boeing closed over the 50-day M.A. at $ 132  in early October thus suggesting a long position.


We bought Bristol Myers at $49.20 with a stop loss at 47.42.


We are long  FFIC at $ 19.10 and  very much interested in the Flushing Financial.


You should have bought the HDGE on a close above 9.65. We paid $ 9.76 on a theoretical buy on the opening Sept 12th. Stop–loss at $ 9.47.


  Name Business Description PE P/S MV mln Price Buy or Sell Limit Stop Loss

Or offset

AMZN Amazon Catalog and Mail Order 200 3.18 388B 819 828 848x
AGN Allergan Pharmaceuticals 20 5.5 91B 230.47 226.00 219x
BMY Bristol Myers Manufacturer


28 4.8 83B 50.02 49.20 47.42x
DY Dycom Materials. Construction Cell Towers internet Infrastructure 25 1.1 2.7B 83.77  Buy 83 81.80xco
BA Boeing Aerospace, commercial jetliners, military systems 14 0.85 81B 135.63  Long at


Stop at 129.70
HL Hecla Mining Basic Materials 44 3.61 1.7B   5.91   3.95 Try to get Long
FFIC Flushing Financial Bank Holding company Savings and loans 13 3,5 592Mln  22.84  19.10


AA Alcoa Aluminum Processing and Technology N/A 0.4 9.5B  26.88 21.15 originally bought 2/8/16 Must hold 30

No new position

T AT&T Communications 36 1.54 211.7B  37.49 34.10 No Current position
VA Virgin Air Regional Airlines 7.2 0.9 1.5B 55.05 30.30


Sell to take profits
ENZ Enzo Biochem Life Sciences NA 1.35 134M  5.93 Bought

 at   5.13


Must hold 50 day m.a.
BAC Bank of America Commercial Bank 10 2.02 165.3B 16.67


Bought  at 15.42 14.60x
HDGE Advisor Shares Ranger Bear ETF   9.74


 Bought at 9.76 9.47sco


Where To Invest October 2016

Stocks To Buy

$100,000 Trading Portfolio Stock Positions and Trades

Each stock is allocated a theoretical $ 5,000 share of the portfolio unless otherwise indicated.




Purchase Price Purchase Date Stop/Loss Price/Date Sold Profit/


AMBA   100   63.75       10/13
LMT        20 233.20       10/10
SAM       20 156.69       10/07
SCO       20 83.31       09/28
SAM       20 151.30       09/23
SPXU   150 24.70       09/13
HDGE  300 9.76       09/12
SCO       20 87.22       08/16
AA         500 10.43       07/25
SPXU    200 23.86       07/14
HL       1000   3.95       05/03
MOS     200 27.53       05/02
EYES    500 5.04       04/04
EYES  1000 6.49       12/28
TWTR  200 28.51       10/28
MOS  100 43.55       08/14
NBGGY  600 1.40       02/17
SAN  600 8.40       12/16
AA  500 14.21       10/16
TEXQY* 200 6.56     7/11
REPR* 5000 0.22 10/22/12


Recommendations will be both listed in this letter and texted to members.


Previous closed out stock and option positions can be found in past Market Strategies Newsletter issues available in the VIP Subscribers Members Area.

For those of you who do not buy puts to protect your portfolio, there are many ETF’s that are the inverse of the DOW. The symbols are DOG, DXD, SDS,TZA and RWM, which go up when the  DOW, S&P 500 and Russell 2000 go down and down when they go up. The DZZ goes up double when gold goes down.


 This Weeks Economic Numbers

Where To Invest October 2016

Market Strategies $100,000 Trading Account


There were two closed out options positions:


the SPY October 212 Puts were sold on the 50% Loss Rule for a loss of $ 408.


The AMBA October 65 Calls were sold at $ 0.95 losing $ 120.


The net for the week was a setback of 528.


There were no closed out stock positions.


For the entire year on closed out trades, our hypothetical profits fell by $ 528 to $21,128.


The options expire on the third Friday of each Month unless otherwise posted.


The Stock table has the following 21 positions:


AA ( 2 ), AMBA, EYES ( 2 ), FAST, HL, MOS( 2 ), NBGGY,

REPR, SAM ( 2 ), SAN, SCO( 2 ), SPXU ( 2 ), SPY, TEXQY, TWTR


The options call for a $ 2,500 investment unless otherwise stated; each stock position requires $5,000 unless otherwise mentioned specifically.


The money management is based on a hypothetical $ 100,000.

We are using a total of $81,149 for the 21 open long stock positions.

There is one option position, the 8 SPY October 28th 213 Puts requiring $ 824

which totals $ 81,973 leaving $ 18,027 in cash.


These figures are approximate and there might be errors.


We have not counted the dividends received from many previous trades such as Apple, Colgate Palmolive, JP Morgan, Mosaic, North American Tankers, STNG, Santander, which pays over 5%, their Brazil affiliate BSBR and Blue Capital Reinsurance which was sold for a profit and many others.


The trading is hypothetical and we do not count commission costs.


Executions that have occurred at or near the open or close of trading sometimes vary from our actual numbers.  For example, when something opens down and it is through our price, we take the next trade whether it is an uptick or continues lower.  This sometimes results in a 50% trade that is slightly above or below the exact number.


Where To Invest October 2016

Previous Week’s Recommendations and

Rules for the Market Strategies

$100,000 Portfolio Trading Account


  • All options count for about $ 2,500.00 for model portfolio calculations unless

otherwise stated


  • When the option has doubled sell half the position


  • Stop Loss protection is either half or offered with each trade


  • The cost of the option is the asking price (or the price between the bid and ask,

whichever is more realistic)


  • The options will be followed until closed out.


  • Option Symbols are stock symbol with expiration month and strike price



Option           COST Date Sold Date Profit/


SPY Oct 28th 213

8 lots



SPY Oct 212

8 lots



10/14/16 0.42 10/18/2016 ( $ 408 )
AMBA Oct 65

8 lots



10/13/16 0.95 10/19/2016 ( $ 120 )


Recommendations will be both listed in this letter and texted to members.


Previous closed out stock and option positions can be found in past Market Strategies Newsletter issues available in the VIP Subscribers Members Area.




MARKET Laboratory – Weekly Changes

Prices are copied from Barron’s Weekly and Yahoo Finance and may be incorrect.









S&P 500








Russell 2000








Gold (spot)












Heating Oil




Unleaded Gas




Natural Gas








Put/Call Ratios

S&P 100



Put/Call Ratios

CBOE Equity





164-26 +1-19


10 Yr. Note

129-274-066   1.74%+0.05%






CRB Inflation





Barron’s* Confidence







5 Yr. Note

120-264 -207

1.24% -0.03%






DJ Utilities
























M1 Money



Oct 10th




M2 Money



Oct 10th





* Component Change in the Confidence Index


M1…all money in hands of the public, Time Deposits Traveler’s Checks, Demand Deposits
M2.. adds Savings and Money Market Accounts both compared with the previous year.



Where To Invest October 2016

Market Strategies Technical Information


                              Support/Resistance Levels:                SUPPORT                         RESISTANCE


S&P 500              2114                                     2160

Dow                  18,045                                  18,300

QQQ             116.20                                  119.50

Transports          7900                                     8125

NASDAQ            5162                                              5340


Last week both the support and resistance levels were tested as the markets have              been getting in narrower trading ranges reflecting a lack of investor conviction.


Text Message Investing Alerts

Where To Invest October 2016

This Weeks’ Economic Numbers

Earnings Releases and Media Data


Before the Open on top of the Row;

After the close below the Economics Information


MONDAY Kimberly-Clark KMB ( 1.54 vs 1.51 ) Philips PHG ( 0.37 vs 0.34 ) T-Mobile US TMUS ( 0.22 vs 0.15 ) V.F. Corp VFC ( 1.15 vs 1.07 ) Western Alliance Bancorp WAL ( 0.65 vs 0.53 )

IMF Chief Christine Lagarde is the keynote speaker at Emerging markets in the world economy,” in Islamabad, Pakistan.

New York Fed President William Dudley speaks.

St Louis Fed President James Bullard gives a presentation on the U.S. economy and monetary policy.

Chicago Fed President Charles Evans discusses current economic conditions and monetary policy.

Crane CR ( 1.01 vs 1.03 ) Everest Re RE ( 4.49 vs 4.53 ) Visa V ( 0.73 vs 0.62 ) Core Logic CLGX ( 0.66 vs 0.54 ) Knowles KN ( 0.30 vs 0.16 ) Zions Bancorp ZION ( 0.50 vs 0.41 )

Sonic SONC ( 0.44 vs 0.43 ) Cadence Design CDNS ( 0.228 vs 0.28 )

TUESDAY Fiat Chrysler FCAU ( 0.35 vs 0.20 ) General Motors GM ( 1.45 vs 1.50 ) Merck MRK ( 0.99 vs 0.96 ) Baker Hughes BHI ( -0.44 vs -0.05 ) Caterpillar CAT ( 0.76 vs 0.75 ) Centene CNC  

( 1.15 vs 0.84 ) DuPont DD ( 0.21 vs 0.13 )Eli Lilly LLY ( 0.96 vs 0.89 )Baxter BAX 0.45 vs0.41 Sprint S ( -0.06 vs -0.15 ) Valero VLO ( 0.93 vs 2.79 ) Whirlpool WHR 3.85 vs 3.45

09:00 hrs Case-Shiller 20-city Index August( 5.1% vs 5.0% )

09:00 hrs NAHB Housing Market Index August ( NA vs 0.5% )

10:00 hrs Consumer Confidence October ( 100.8 vs 104.1 )

AT&T T ( 0.74 vs 0.74 ) Apple AAPL ( 1.65 vs 1.96 )  Ameriprise AMP 2.42 vs 2.35 Capital One COF ( 1.94 vs 2.10 ) C.H. Robinson CHRW ( 0.96 vs 0.96 ) Owens Illinois OI ( 0.66 vs 0.57 )NCR Corp NCR 0.81 vs 0.79 WR Berkley WRB 0.84 vs 0.91 Chubb CB  2.58 vs 2.37 

WEDNESDAY Coca-Cola KO ( 0.48 vs 0.51 ) Comcast CMCSA 0.91 vs 0.80 Boeing BA 2.62 vs 2.52 Avery Dennison AVY ( 1.00 vs 0.87 ) General Dynamics GD 2.38 vs 2.28  Mondelez MDLZ ( 0.43

Vs 0.42 ) Northrop Grumman ( NOC 2.81 vs 2.75 ) Owens Corning OC ( 1.00 vs 0.96 )


07:00 hrs MBA Mortgage Index 10/22 ( NA vs -0.6% )

08:30 hrs International Trade in Goods September ( NA vs -$58.4Bln )

10:00 hrs New Home Sales September ( 610K vs 609K )

10:30 hrs Crude Inventories 10/22 ( NA vs -5.247 Mln Bbls )

Barrick Gold ABX ( 0.21 vs 0.11 ) Newmont Mining NEM ( 0.50 vs 0.23 ) Groupon GRPN      -0.02 vs 0.05  Goldcorp GG ( 0.12 vs 0.04) Kirby KEX 0.56 vs 1.04 NXP NXPI 1.59 vs 1.57

THURSDAY Aetna AET ( 2.03 vs 1.90 ) Air Products APD 1.98 vs 1.82 Bristol-Myers BMY 0.65 vs 0.39

Celgene CELG 1.48 vs 1.23 ConocoPhillips COP -0.67 vs-0.38 Colgate-Palmolive CL 0.73 vs 0.80 Dow Chem DOW 0.79 vs 0.82 HCA 1.42 vs 1.17 Goodyear Tire GT 1.16 vs 0.99 Raytheon RTN 1.64 vs 1.47 Sony 13.89 vs 26.10 UPS ( 1.44 vs 1.39 ) TMO 1.97 vs 1.80

08:30 hrs Initial Claims 10/22 ( 259K vs 260K  )

Continuing Claims  10/15 ( NA vs 2057K  )

08:30 hrs Durable Goods Orders September ( 0.0% vs 0.0% )

D.G. Ex-Transportation September ( 0.3% vs -0.4% )

10:00 hrs Pending Home Sales September ( 0.6% vs -2.4% )

10:30 hrs Natural Gas Inventories 10/22 ( NA vs 77bcf )

Amazon AMZN  0.77 vs 0.17 Amgen AMGN 2.80 vs 2.72 Alphabet GOOG 8.62 vs 7.35 ) AFLAC AFL 1.74 vs 1.32 Eastman Chemical EMN 1.67 vs 1.84 McKesson MCK 3.06 vs 3.31 Republic Services RSG (0.58 vs 0.53 ) Stryker SYK 1.37 Twitter TWTR 0.09 vs 0.10  

FRIDAY Anheuser-Busch BUD 1.01 vs 1.02 AbbVie ABBV 1.20 vs 1.13 AutoNation AN 1.15 vs 1.05

Chevron CVX 0.40 vs 1.09 Exxon Mobil XOM 0.57 vs 1.01 Hershey Foods HSY 1.19 vs 1.17

Phillips 66 PSX 0.88 vs 3.02 MasterCard MA 0.98 vs 0.91 Newell NWL 0.73

08:30 hrs GDP-Advanced 3rd Qtr ( + 2.5% vs 1.4% )

08:30 hrs Implicit Price Deflator 3rd Qtr ( 1.4% vs 2.3 % )

08:30 hrs Employment Cost Index 3rd Qtr ( + 0.6% vs +0.6% )

10:00 hrs Michigan Sentiment October Final ( 88.2 vs 87.9 )

U.S. Oil Rig Count rose by eleven Rigs to 443 The Nat Gas rig count rose by3 to 108, and there are two rigs listed as miscellaneous making a total US rig count of 553. . Crude closed higher at $ 50.85 up $ 0.50.The total rig count is lower by 234 from a year earlier. Natural Gas closed the week much lower for the week, off 9% at $ 2.993 down  $ 0.292.



Where To Invest October 2016

Market Strategies Fundamentals

Stocks opened the week significantly lower on expectations of continued weak earnings reports. The S&P 500 closed on Monday at 2126.50, a loss of 6.5 points or 3% on the day, however, a complete recovery and rally to 2141.16 by Friday’s close put the index up 8 points on the week a gain of 0.38%.

DJIA 18138.38 18145.71 7.33 0.0 4.1
Nasdaq 5214.16 5257.40 43.24 0.8 5.0
S&P 500 2132.98 2141.16 8.18 0.4 4.8
Russell 2000 1212.41 1218.11 5.70 0.5 7.2

The S&P leaders for the week were Netflix Inc ( NFLX: $ 127.50 ) + $26.03 or + 25.7%; CF Industries Holdings Inc ( CF: $ 25.92 ) + $ 3.64 or + 16.3%; Reynolds American ( RAI: $ 53.78 ) + $ 6.51 or + 13.8%; Harley-Davidson Inc ( HOG: $ 56.37 ) + $ 6.44 or + 12.9%; PayPal Holdings Inc ( PYPL: $ 44.15 ) + $ 4.91 or + 12.5%; and Time Warner ( TWX: $ 89.48 ) + $ 9.93 or + 12.5%. The biggest weekly losses were: Southwestern Energy ( SWN: $11.90 ) – $ 1.31 or down 10.2%; Assurant, Inc         ( AIZ: $ 82.81 ) -$ 8.17 or – 9%; eBay Inc ( EBAY: $ 29.06 ) – $ 2.83 or – 8.9%; Genuine Parts                  ( GPC: $ 90.59 ) – $ 7.42 or -7.6%; and Union Pacific Corp ( UNP: $ 90.37 ) – $ 6.47 or – 6.7%.

The Dow responded in a similar fashion opening the week off 52 points at 18,086 but recovered to 18,145.71, a gain of 7.33 points or + 0.04% for the week. The biggest winners were American Express Co ( AXP: $ 67.36 ) + $ 7.21 or + 12%; United Health Group ( UNH: $ 145.37 ) + $ 11.45 or + 8.6%; and Microsoft ( MSFT: $ 59.66 ) + 2.24 or + 3.9%. The big weekly decliners were Intel ( INTC: $ 35.15) – $ 2.30 or -6.1%; Travelers Companies Inc ( TRV: $ 108.35 ) – $ 6.73 or – 5.9%; Procter and Gamble Co ( PG: $ 84.33 ) – $ 4.10 or – 4.6%; and Johnson and Johnson ( JNJ: $ 113.44 ) – $ 4.12 or – 3.5%.

The Nasdaq was by far the most impressive index after a similar slow start Monday making a gain of 43 points or 0.83% for the week. The Nasdaq finally reclaimed its 50 day moving average and reaching up to its 13 day m.a. Exponent ( EXP: $ 56.41 ) + $ 7.71 or + 15.8% breached its 50 and 200 day moving averages; Theravance Biopharma ( TBPH: $ 33.54 ) + $ 4.51 or + 15.5%.

Basic Materials was the strongest Dow Industrial up 2.05% and  led all sectors by a significant margin: AK Steel ( AKS: $ 5.16 ) + $ 0.65 or + 14.4%; Hecla Mining ( HL: $ 5.91 ) + $ 0.67 or + 12.8%; and Cliffs Natural Resources ( CLF: $ 6.01 ) + $ 0.67 or + 12.5%.Financials were the next best group rising 0.93% followed by Consumer Services up 0.85%; Technology gaining 0.70%; Oil and Gas up 0.53%; Utilities gained 0.51% and lastly, Health Care, up 0.23%. Telecommunications was by far the biggest loser off 3.54%, followed by Consumer Goods, down 0.18% and Industrials off just 0.16%.

The US dollar ( DXYO: 98.09 ) +0.61 or plus 0.6% had another great week making a gain of 3,4% over the last three weeks.  The greenback’s strength was partly a function of safe-haven flows and  interest-rate differentials.

Volatility ( VIX: $13.34 -2.78 ) declined  17.3% last week.  Lower volatility is usually bullish for stocks. The more volatile ProShares Ultra Vix Short-Term volatility futures ( UVXY: $ 14.23 ) – $ 3.35 or – 19.1% fell to its lowest level in three months since July.


Debt Levels are Unsustainable and Politics are Toxic

While interest rates have been low, governments have loaded up on debt. Now, a certain catch-22 is developing.

Governments are continually rolling over debt at very low rates, but if we went back to normal rates, given that they gigantically increased government debts, the effect on fiscal policy for governments would be nearly catastrophic. This situation is similar to heroin addiction, with an eventual crash and withdrawal coming at some point.

Central banks should have started to raise rates more quickly to counteract the compound effects on pension funds, he said. Now, however, because of the amount of debt outstanding, raising rates would have terrible impacts not only on governments but also corporations.


On the following table long positions have declined sharply in five of the last six weeks to roughly 189, 243 from 301,769 in the first week of September.

Barrick Gold (ABX: $ 16.92 ) + $ 1.23 or + 7.8% for last week. ABX will release its results for the third quarter on Wednesday after the close.  Investors will be expecting Barrick to sustain the momentum that it has gained over the past week.

In fact, the spot price of gold has moved up nearly 1% from the recent low of $1,252 per ounce to $1,265 per ounce. This has given Barrick shares a shot in the arm going into its quarterly report. Once Barrick releases its results next week, the stock will receive another shot in the arm since it is on track to deliver solid growth. Why Barrick will witness strong growth

There are two reasons why Barrick Gold is on track to deliver robust earnings growth for the third quarter – improved pricing and lower costs. In the recently-concluded third quarter, Barrick should witness an average realized price of above $1,300 an ounce. In comparison, in the year-ago period, Barrick’s average realized price of gold came in at $1,125 an ounce.

This indicates that on a year-over-year basis, the company’s average realized price per ounce of gold should increase by more than 16%. This increment in the gold price will lead to an improvement in margins. But, investors should not miss the fact that the growth in Barrick’s margins will also be driven by a consistent cost base.


NOTE: This is a Sample Issue Only!



Visit: PrincetonResearch.com/join.htm



For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm




Go To http://www.princetonresearch.com/join.htm

To get the lowest full membership rates available now.


Investing Trade Alerts

Where To Invest October 2016

Market Strategies Economic Data

Industrial Production increased just 0.1% in September (Briefing.com consensus +0.2%) after declining a downwardly revised 0.5% (from -0.4%) in August. The capacity utilization rate increased to 75.4% (Briefing.com consensus 75.6%) from a downwardly 75.3% (from 75.5%). Utilities output was down 1.0% on the heels of a 0.3% decline in August.

The small uptick in September was paced by a 0.2% increase in manufacturing output, which was driven by a 0.5% increase in the production of nondurables. The production of durables was unchanged.

Motor vehicle assemblies rose slightly to a seasonally adjusted annual rate of 12.28 million units from 12.24 million units in August. Mining output was up 0.4% after declining 1.0% in August.

Total industrial production was 1.0% lower in September than the year-ago level. Meanwhile, the capacity utilization rate of 75.4% is running 4.6 percentage points below its long-run average.

The key takeaways from this report are that industrial output remains soft, which is a headwind for GDP growth, and that capacity utilization remains weak, which suggests a lack of inflation bottlenecks and little need to construct new capacity.

Industrial Production
Total Index 0.1% -0.5% 0.5% 0.5% -0.2%
    Manufacturing 0.2% -0.5% 0.4% 0.2% -0.2%
    Utilities -1.0% -0.3% 0.3% 2.9% -0.5%
    Mining 0.4% -1.0% 1.1% 0.1% 0.8%
Capacity Utilization
Total Industry 75.4% 75.3% 75.8% 75.4% 75.1%
    Manufacturing 74.9% 74.8% 75.2% 75.0% 74.8%





Housing Starts declined 9.0% in September to a seasonally adjusted annual rate of 1.047 million units (Briefing.com consensus 1.168 million). Building permits — a leading indicator — increased 6.3% to a seasonally adjusted annual rate of 1.225 million (Briefing.com consensus 1.164 million).However, One shouldn’t take the September housing starts report at face value. It wasn’t as bad as the lead headlines suggest. Single-family starts increased by a solid 8.1% to 783,000, the highest rate since February.

Starts for multi-unit dwellings declined 38% to a seasonally adjusted annual rate of 264,000, but single-family starts rose 8.1% to 783,000.

Permits to build single-family homes rose 0.4%, suggesting that new home construction should continue on a steady, albeit modest, pace.

Single-family starts were up in all regions, with the exception of the West (-2.2%). The Northeast led the way with a 20.0% increase, followed by the South (+12.1%), which is the nation’s biggest region for new home construction, and the Midwest (+6.3%).

The number of housing units under construction at the end of the period was roughly flat at 1.038 million; however, this should still be a positive input in Q3 GDP forecasts since the third quarter average of 1.035 million is 3.0% higher than the second quarter average.

Starts 1047K 1150K 1218K 1195K 1128K
  1 Unit 783K 724K 769K 763K 737K
  Multi Units 264K 426K 449K 432K 391K
Permits 1225K 1152K 1144K 1153K 1136K




The Conference Board’s Leading Economic Index (LEI) increased 0.2% in September, as expected, rebounding from an unrevised 0.2% decline in August. Positive contributions from building permits (+0.19 percentage points), the interest rate spread (+0.14 percentage points), and average weekly initial claims (+0.13 percentage points) were the difference makers in September. The remaining components were either up marginally or negative.

The biggest drag on the LEI in September was the average workweek (-0.07 percentage points).

Over the six-month period ending September 2016, the LEI increased 1.1% versus growth of 0.3% over the previous six months.

The Coincident Economic Index increased 0.2% in September after being unchanged in August.

The Lagging Economic Index was also up 0.2% for the second straight month.

Total Index 0.2% -0.2% 0.5% 0.2% -0.2%
  Manufacturing Workweek -0.07% -0.13% 0.20% -0.13% 0.07%
  Initial Claims 0.13% -0.05% 0.07% 0.15% -0.23%
  Cons. Gds Orders 0.01% 0.01% 0.01% 0.02% -0.10%
  ISM New Orders -0.01% -0.13% 0.03% 0.03% 0.01%
  Nondef. Cap Gds Orders, exc. Aircraft -0.01% 0.04% 0.04% 0.01% -0.03%
  Building Permits 0.19% 0.02% -0.02% 0.05% 0.02%
  Stock Prices -0.04% 0.05% 0.12% 0.04% -0.02%
  Leading Credit Index -0.01% 0.00% 0.07% 0.03% 0.02%
  Interest Rate Spread 0.14% 0.13% 0.12% 0.14% 0.16%
  Consumer Expectations 0.01% -0.01% -0.06% 0.00% -0.01%


Where To Invest October 2016

Market Strategies Cycles


As of today’s close, the Seasonal MACD Buy Signal is still on Hold. The STA MACD “Buy” indicator applied to DJIA is positive, but S&P 500 and NASDAQ remain negative. In order to issue the Seasonal MACD Buy Signal, DJIA, S&P 500 and NASDAQ MACD “Buy” indicators need to signal a “Buy” and all must be in agreement.


ETF Portfolio Updates


Per last update from earlier this month on October 4, SPDR Utilities (XLU) has been closed out of the portfolio. XLU was closed out using its average price on October 5 for a modest 4.0% return excluding dividends paid while it was held. Recent rate hike expectations and a stronger U.S. dollar have resulted in iShares 20+ Year Treasury Bond (TLT) being stopped out on October 11 when it closed below its stop loss of $133.00. Price only return was a meager 0.2%, but with monthly dividends included it is better as they totaled around $1.50 since May. Our other bond holding, iShares Core US Aggregate Bond (AGG) is still on Hold.


Recent volatility did allow the addition of iShares NASDAQ Biotech (IBB), SPDR Consumer Staples (XLP), SPDR Healthcare (XLV) and Vanguard REIT (VNQ). As of yesterday’s close, IBB, XLP and XLV were still trading below their respective buy limits and can be considered at current levels. VNQ was 2.3% higher yesterday and can be considered on dips below its buy limit.


This month’s Seasonal Sector Trade idea, CurrencyShares British Pound (FXB) was added to the portfolio on October 11 at $120.00. The pound’s mini crash appears to have put in a bottom as the low on the eleventh has held thus far. FXB is on Hold. Significant uncertainty remains as to the effects of Brexit, but since most of the disastrous consequences have not materialized and may not there is room for a pound bounce. If the bounce fails, the tight stop loss should be heeded at $117.90.


Numerous positions in the portfolio remain open with buy limits that are below current market levels. In some cases, well below. IYW, IYT, IYZ, SOXX, XLY, XLB and XLK can all be considered on dips below their respective buy limits. Any positions not added before our Seasonal MACD Buy Signal will be considered when we issue the Seasonal Buy.





Rule 17B Attestations and Disclaimers


Princeton Research, Inc. has approximately 2,581,578 shares of AIVN both free and restricted and represents them for Investor relations. Princeton also has about 40,000 shares of TXGE. Princeton is paid $ 1,500 per month from RMS Medical Products. Princeton has bought 81,100 shares of RMS Medical Products. Princeton was paid $ 2,500 to write a report on Xinergy. Princeton has signed a contract with CBLI to be paid $ 2500 for July and August for investor relations. Princeton has been engaged by Target Energy. No contract is currently in place. Princeton was paid about 500,000 restricted shares of Leo Motors.


When there is no movement in penny stocks, even though there is none or very small losses, we will liquidate ( sold AIVN on stop ) even though we like the company, if money is needed for better opportunities.


We now believe REPR represents upside opportunity. The Target ADR trades at about $ 4.50 in U.S. vs 0.05 in Australia. Princeton owns 400,000 Australia shares and about 900 U.S. ADR’s.


Pursuant to the provisions of Rule 206 (4) of the Investment Advisers Act of 1940, readers should recognize that not all recommendations made in the future will be profitable or will equal the performance of any recommendations referred to in this e-mail issue. Princeton may buy or sell its free-trading shares in companies it represents at any time.




Please Direct All Inquiries To:


Mike King

(702) 650-3000



Charles Moskowitz

 (781) 826-8882



Princeton Research

3887 Pacific Street,

Las Vegas, Nevada 89121


Fax: (702) 697-8944


Where to Invest in 2016

Where To Invest October 2016 Report